Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

81.29
BATS BZX Real-Time Price
As of 11:43am ET
 +0.24 / +0.30%
Today’s Change
77.92
Today|||52-Week Range
120.37
-19.67%
Year-to-Date
Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More
10:28am / Zacks.com - Paid Partner Content
Harvoni Sales Declines Hurt Gilead Sciences Inc. in Q2
Jul 26 / MotleyFool.com - Paid Partner Content
The Drug-Price War Just Took a Big New Twist
10:24am / MotleyFool.com - Paid Partner Content
Gilead Sciences (GILD) Stock Plunges on Q2 Results, RBC Cuts Price Target
Jul 26 / TheStreet.com - Paid Partner Content
Buy Gilead Sciences While It's Wallowing
7:36am / TheStreet.com - Paid Partner Content
3 Stocks Dragging The Health Care Sector Downward
Jul 26 / TheStreet.com - Paid Partner Content
Buy Gilead Sciences While It's Wallowing
7:21am / TheStreet.com - Paid Partner Content
3 Key Takeaways Following Gilead Sciences' Second-Quarter Conference Call
Jul 26 / MotleyFool.com - Paid Partner Content
After GILD Earnings, Which Biomed Stock is Best Right Now?
Jul 26 / Zacks.com - Paid Partner Content
Jerome Dodson Comments on Gilead
Jul 26 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close81.05
Today’s open81.30
Day’s range81.07 - 81.79
Volume449,655
Average volume (3 months)10,226,672
Market cap$107.9B
Dividend yield2.31%
Data as of 11:43am ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-6.37%
Earnings growth (next 5 years)-1.20%
Revenue growth (last year)+28.71%
P/E ratio7.0
Price/Sales4.80
Price/Book6.22

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+1.36+0.81%
BIIBBiogen+0.45+0.16%
BAXBaxter International...+0.03+0.06%
NBIXNeurocrine Bioscienc...+0.45+0.91%
Data as of 11:44am ET, 07/27/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$3.00
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs